CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.

about

CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q35638549

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@ast

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@en

type

Item

label

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@ast

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@en

prefLabel

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@ast

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@en

P1476

CHOP-like-14 compared to CHOP- ...... randomized controlled trials.

@en

P2093

Anat Gafter-Gvili

http://www.w3.org/2001/XMLSchema#string

Ina Monsef

http://www.w3.org/2001/XMLSchema#string

Liat Vidal

http://www.w3.org/2001/XMLSchema#string

Ofer Shpilberg

http://www.w3.org/2001/XMLSchema#string

Pia Raanani

http://www.w3.org/2001/XMLSchema#string

Ron Ram

http://www.w3.org/2001/XMLSchema#string

Ronit Gurion

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Measuring inconsistency in meta-analyses

Practical methods for incorporating summary time-to-event data into meta-analysis

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed.

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.3109/0284186X.2015.1043025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25997705

http://www.w3.org/2001/XMLSchema#string